UM
Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1)
Zheng Y.2; Guo C.2; Zhang Y.2; Qi H.2; Sun Q.2; Xu E.2; Zhang Y.2; Ma D.2; Wang Y.2
2011-12-01
Source PublicationInternational Immunopharmacology
ISSN15675769 18781705
Volume11Issue:12Pages:2188-2193
AbstractHuman chemokine-like factor (CKLF1) is a human cytokine that exhibits chemotactic activities on a wide spectrum of leukocytes. One of CKLF1's C-terminal peptides, C19, exerts inhibitory effects on chemotaxis mediated by mouse Ccr3 and Ccr4 and human CCR3 and CCR4. Mouse models of asthma show that C19 can also inhibit the Th2 response. CCR3 and CCR4 are chemokine receptors important to allergic rhinitis, a condition whose pathogenesis is similar to that of asthma. Here, we established a mouse model of allergic rhinitis by repetitive sensitization and intranasal challenge with OVA and assessed whether C19 has therapeutic effects on this model. In this study, both intranasal and intraperitoneal administration of C19 reduced allergic symptoms such as sneezing and rubbing and serum concentration of IgE. C19 showed a strong ability to suppress eosinophil accumulation in nasal mucosa and lung tissues. C19 was able to suppress the Th2 cytokine IL-4 without augmenting the Th1 cytokine IFN-γ in BAL and IL-4 cells in the local nasal tissue. In terms of symptom amelioration, IgE reduction, and eosinophilia suppression, C19 was found to be as effective against allergic rhinitis as Budesonide. Moreover, intranasal treatment has a stronger therapeutic effect than other types of administration, and it may be more convenient and safe. For these reasons, C19 may have potential in the treatment of allergic rhinitis. © 2011 Elsevier B.V.
KeywordAllergic rhinitis Animal models CKLF1 Peptide
DOI10.1016/j.intimp.2011.09.017
URLView the original
Language英語
Fulltext Access
Citation statistics
Cited Times [WOS]:11   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Affiliation1.Ministry of Health of People's Republic of China
2.Peking University
Recommended Citation
GB/T 7714
Zheng Y.,Guo C.,Zhang Y.,et al. Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1)[J]. International Immunopharmacology,2011,11(12):2188-2193.
APA Zheng Y..,Guo C..,Zhang Y..,Qi H..,Sun Q..,...&Wang Y..(2011).Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1).International Immunopharmacology,11(12),2188-2193.
MLA Zheng Y.,et al."Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1)".International Immunopharmacology 11.12(2011):2188-2193.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zheng Y.]'s Articles
[Guo C.]'s Articles
[Zhang Y.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zheng Y.]'s Articles
[Guo C.]'s Articles
[Zhang Y.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zheng Y.]'s Articles
[Guo C.]'s Articles
[Zhang Y.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.